NCT01733446

Brief Summary

The investigators data reveal an important new observation regarding the recovery of breathing during emergence from general anesthesia: respiration resumes as a prolonged abdominal expiration event. The present study aims to further clarify the physiology of recovery of breathing with the addition of a cutaneous monitor for arterial carbon dioxide measurement and a comparison of two different recovery paradigms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable surgery

Timeline
Completed

Started Sep 2012

Longer than P75 for not_applicable surgery

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 2, 2012

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 27, 2012

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2018

Completed
Last Updated

April 23, 2018

Status Verified

April 1, 2018

Enrollment Period

5.4 years

First QC Date

October 2, 2012

Last Update Submit

April 20, 2018

Conditions

Keywords

High frequency jet ventilation

Outcome Measures

Primary Outcomes (1)

  • spontaneous breathing

    The primary variable will be first breath as detected by Respiratory Inductance Plethysmography (RIP. This will occur in the operating room at the end of the surgery and anesthesia.)

    Day 0 in the operating room occurring in the specific time frame of the end of anesthesia to patient 's first breath

Study Arms (2)

Standard anesthesia regimen

NO INTERVENTION

Positive pressure ventilation will be stopped at the same time infusions of anesthetic agents and spontaneous ventilation employed until emergence from anesthesia is observed. (This is standard protocol for everyday anesthesia management of this population.)

Continuation of High Frequency Jet Ventilation ( HFJV)

EXPERIMENTAL

In Group B after cessation of anesthetic infusions, High Frequency Jet Ventilation (HFJV) will continue through the endotracheal tube. Patient will be extubated when awake. Respiratory Inductance Plethysmography (RIP) and transcutaneous carbon dioxide (PtcCO2) measurements will continue for the duration of emergence.

Other: Continuation of High Frequency Jet Ventilation (HFJV)

Interventions

In Group B, after cessation of anesthetic infusions, High Frequency Jet Ventilation (HFJV) will continue through the endotracheal tube. Patient will be extubated when awake. Respiratory Inductance Plethysmography (RIP) and Transcutaneous carbon dioxide (PtcCO2) measurements will continue for the duration of emergence.

Continuation of High Frequency Jet Ventilation ( HFJV)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or Female patients ages \> 18 to \< 80
  • Scheduled for procedures under general anesthesia with jet ventilation
  • Sign informed consent
  • Candidate for total intravenous anesthesia with propofol and remifentanil (which is standard protocol in this type of population)

You may not qualify if:

  • Absence of informed consent
  • No planned use intra-operative use of jet ventilation
  • Known difficulties with jet ventilation during prior surgical procedures
  • Emergency surgery
  • Baseline (oxygen saturation)SpO2 \<92% on room air
  • BMI \> 50
  • Pregnant or lactating females
  • Skin damage, rash or significant lesions in the areas covered by the RIP bands or transcutaneous CO2 sensor.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

Study Officials

  • Joshua H Atkins, MD PhD

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 2, 2012

First Posted

November 27, 2012

Study Start

September 1, 2012

Primary Completion

February 1, 2018

Study Completion

February 1, 2018

Last Updated

April 23, 2018

Record last verified: 2018-04

Locations